Synthroid

Product NDC: 66336-591
11-digit product format: 663360591
Labeler code: 66336
Product ID: 66336-591_c12f402b-f00b-466d-a6ea-862f00f81ec7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Levothyroxine Sodium
Dosage form: TABLET
Route: ORAL
Labeler: Dispensing Solutions, Inc.
Application: NDA021402
Marketing category: NDA
Marketing start: 2002-07-24
Marketing end: 0000-00-00
Substance: LEVOTHYROXINE
Active strength: 150 ug/1
Pharmacologic classes: l-Thyroxine [EPC],Thyroxine [CS]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	66336-591		I	Inactivated by FDA		2026-08-17
excluded package	package	66336-591	66336-591-30	I	Inactivated by FDA		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	66336-591-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	66336-591-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	66336-591-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	66336-591-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	66336-591-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	66336-591-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	66336-591-30	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	66336-591-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	66336-591-30	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	66336-591-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	66336-591-30	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	66336-591-30	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	66336-591-30	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	66336-591-30	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	66336-591-30	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	66336-591-30	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	66336-591-30	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	66336-591-30	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	66336-591-30	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	66336-591-30	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	66336-591-30	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	66336-591-30	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021402-001	SYNTHROID	LEVOTHYROXINE SODIUM	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-002	SYNTHROID	LEVOTHYROXINE SODIUM	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-003	SYNTHROID	LEVOTHYROXINE SODIUM	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-004	SYNTHROID	LEVOTHYROXINE SODIUM	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-005	SYNTHROID	LEVOTHYROXINE SODIUM	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-006	SYNTHROID	LEVOTHYROXINE SODIUM	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-007	SYNTHROID	LEVOTHYROXINE SODIUM	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-008	SYNTHROID	LEVOTHYROXINE SODIUM	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-009	SYNTHROID	LEVOTHYROXINE SODIUM	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-010	SYNTHROID	LEVOTHYROXINE SODIUM	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24
N021402-011	SYNTHROID	LEVOTHYROXINE SODIUM	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD, RS	2002-07-24
N021402-012	SYNTHROID	LEVOTHYROXINE SODIUM	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 24 matching rows.

Application-product, TE code table
Application-product	TE code
N021402-001	AB1
N021402-001	AB2
N021402-002	AB1
N021402-002	AB2
N021402-003	AB1
N021402-003	AB2
N021402-004	AB1
N021402-004	AB2
N021402-005	AB1
N021402-005	AB2
N021402-006	AB1
N021402-006	AB2
N021402-007	AB1
N021402-007	AB2
N021402-008	AB1
N021402-008	AB2
N021402-009	AB1
N021402-009	AB2
N021402-010	AB1
N021402-010	AB2
N021402-011	AB1
N021402-011	AB2
N021402-012	AB1
N021402-012	AB2

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 13 · 504 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N021402-001	SYNTHROID	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-002	SYNTHROID	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-003	SYNTHROID	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-004	SYNTHROID	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-005	SYNTHROID	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-006	SYNTHROID	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-007	SYNTHROID	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-008	SYNTHROID	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-009	SYNTHROID	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-010	SYNTHROID	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-011	SYNTHROID	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD, RS	2002-07-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-012	SYNTHROID	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021402-001	SYNTHROID	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-002	SYNTHROID	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-003	SYNTHROID	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-004	SYNTHROID	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-005	SYNTHROID	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-006	SYNTHROID	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-007	SYNTHROID	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-008	SYNTHROID	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-009	SYNTHROID	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-010	SYNTHROID	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-011	SYNTHROID	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD, RS	2002-07-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-012	SYNTHROID	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-001	SYNTHROID	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-002	SYNTHROID	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-003	SYNTHROID	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-004	SYNTHROID	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-005	SYNTHROID	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-006	SYNTHROID	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-007	SYNTHROID	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-008	SYNTHROID	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-009	SYNTHROID	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-010	SYNTHROID	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-011	SYNTHROID	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD, RS	2002-07-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021402-012	SYNTHROID	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021402-001	SYNTHROID	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021402-002	SYNTHROID	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021402-003	SYNTHROID	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021402-004	SYNTHROID	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	TABLET / ORAL	AB1,AB2	RLD	2002-07-24	`6a471c1ec25d…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 26 · 1,008 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N021402-001	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-001	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-002	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-002	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-003	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-003	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-004	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-004	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-005	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-005	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-006	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-006	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-007	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-007	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-008	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-008	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-009	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-009	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-010	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-010	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-011	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-011	AB2	2	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-012	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021402-012	AB2	2	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021402-001	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-001	AB2	2	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-002	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-002	AB2	2	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-003	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-003	AB2	2	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-004	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-004	AB2	2	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-005	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-005	AB2	2	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-006	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-006	AB2	2	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-007	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-007	AB2	2	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-008	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021402-008	AB2	2	`011fe1cb6892…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
97c252d3-9bb8-4530-bb44-9824dc7cf556	Product name	6	20250729
6c43b71c-35e6-4db3-ba24-c6ef42ff7003	Product name	3	20240207
890fd4bf-1a80-42b7-be1b-2d0259d5f0c8	Product name	5	20240207
c8ad26bf-af73-460b-b74e-1eff16cc4f9f	Product name	5	20240207
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
01383843-4069-43cf-aa76-dc17a6f9f8c4	Product name	2	20230123
978cca7d-a938-4791-8322-da48d90a63ef	Product name	1	20230113
65f86ba3-8816-4e12-899b-18290c8de551	Product name	2	20210614
f16ab90f-08c2-40be-a543-66d9827cd1f3	Product name	1	20210601
6a33ec05-2ae2-45e5-ab82-2d94b3303923	Product name	1	20190709
93355a10-1c44-4c92-a11d-7d995e0200d9	Product name	1	20190219

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
66336-591-30	2019-11-27	C162847	48780-1	9855d018-d571-cd31-e053-dbdaa90ab51a	SYNTHROID® (levothyroxine sodium tablets, USP)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
66336-591-30	Synthroid	30 in 1 BOTTLE, PLASTIC	TABLET	30		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LEVOTHYROXINE	ACTIVE INGREDIENT	Q51BO43MG4	SYNTHROID (LEVOTHYROXINE SODIUM) TABLET [DISPENSING SOLUTIONS, INC.]	2
LEVOTHYROXINE	ACTIVE MOIETY	Q51BO43MG4	SYNTHROID (LEVOTHYROXINE SODIUM) TABLET [DISPENSING SOLUTIONS, INC.]	2
ACACIA	INACTIVE INGREDIENT	5C5403N26O	SYNTHROID (LEVOTHYROXINE SODIUM) TABLET [DISPENSING SOLUTIONS, INC.]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	SYNTHROID (LEVOTHYROXINE SODIUM) TABLET [DISPENSING SOLUTIONS, INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	SYNTHROID (LEVOTHYROXINE SODIUM) TABLET [DISPENSING SOLUTIONS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SYNTHROID (LEVOTHYROXINE SODIUM) TABLET [DISPENSING SOLUTIONS, INC.]	2
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	SYNTHROID (LEVOTHYROXINE SODIUM) TABLET [DISPENSING SOLUTIONS, INC.]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	SYNTHROID (LEVOTHYROXINE SODIUM) TABLET [DISPENSING SOLUTIONS, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
66336-591	SYNTHROID (LEVOTHYROXINE SODIUM) TABLET [DISPENSING SOLUTIONS, INC.]	2	Legacy NDC, 1 package rows	20130926_00eea4aa-f08e-419a-827a-56e40e93f05f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Synthroid	LEVOTHYROXINE SODIUM	AbbVie Inc.	1e11ad30-1041-4520-10b0-8f9d30d30fcc	2024-02-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021402 application number: NDA021402

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
Q51BO43MG4	LEVOTHYROXINE	51-48-9	LEVOTHYROXINE
9J765S329G	LEVOTHYROXINE SODIUM	6106-07-6	Levothyroxine Sodium

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
966225	levothyroxine sodium 150 MCG Oral Tablet	PSN	00eea4aa-f08e-419a-827a-56e40e93f05f	2
966201	SYNTHROID 150 MCG Oral Tablet	PSN	00eea4aa-f08e-419a-827a-56e40e93f05f	2
966201	levothyroxine sodium 0.15 MG Oral Tablet [Synthroid]	SBD	00eea4aa-f08e-419a-827a-56e40e93f05f	2
966225	levothyroxine sodium 0.15 MG Oral Tablet	SCD	00eea4aa-f08e-419a-827a-56e40e93f05f	2
966225	levothyroxine sodium 150 MCG Oral Tablet	SY	00eea4aa-f08e-419a-827a-56e40e93f05f	2
966201	Synthroid 0.15 MG Oral Tablet	SY	00eea4aa-f08e-419a-827a-56e40e93f05f	2
966201	Synthroid 150 MCG Oral Tablet	SY	00eea4aa-f08e-419a-827a-56e40e93f05f	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
66336-591-30	66336059130	30 in 1 BOTTLE, PLASTIC	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
SYNTHROID® (levothyroxine sodium tablets, USP)	Dispensing Solutions, Inc. \| PSS World Medical, Inc.	2013-09-25	HUMAN PRESCRIPTION DRUG LABEL	2